# Study on the Bioavailability of Three Different Prescription Processes of SHR4640 Tablets in Healthy Volunteers

> **NCT04586803** · PHASE1 · UNKNOWN · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 24 (estimated)

## Conditions studied

- Primary Gout
- Hyperuricemia

## Interventions

- **DRUG:** SHR4640

## Key facts

- **NCT ID:** NCT04586803
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-10
- **Primary completion:** 2020-11
- **Final completion:** 2020-12
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2020-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04586803

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04586803, "Study on the Bioavailability of Three Different Prescription Processes of SHR4640 Tablets in Healthy Volunteers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04586803. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*